342 related articles for article (PubMed ID: 26161390)
1. Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?
Wong A; Ngeow J
Biomed Res Int; 2015; 2015():219012. PubMed ID: 26161390
[TBL] [Abstract][Full Text] [Related]
2. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G; Manfredini M; Tomasi A; Pellacani G
Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
[TBL] [Abstract][Full Text] [Related]
3. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
4. Skin lesions with Lynch syndrome could represent Muir-Torre syndrome.
Siddiqui N; Tariq Z; Gaba C; Hamouda D; Nawras A; Ul Rehman S; Mohamed IE
Int J Colorectal Dis; 2014 Aug; 29(8):1013-4. PubMed ID: 24793211
[No Abstract] [Full Text] [Related]
5. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
6. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
[TBL] [Abstract][Full Text] [Related]
7. Hereditary non-BRCA gynecological tumors.
Vellone VG; Paudice M; Varesco L
Minerva Ginecol; 2016 Oct; 68(5):579-86. PubMed ID: 26930387
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
[TBL] [Abstract][Full Text] [Related]
9. New Insights into Lynch Syndrome: A Narrative Review.
Ene CV; Bulai CTLA; Geavlete P; Popescu RI; Vacaroiu IA; Georgescu DE; Isaconi IV; Munteanu MDLA; Ene CD; Militaru A; Geavlete B; Multescu R
Chirurgia (Bucur); 2023 Dec; 118(6):584-595. PubMed ID: 38228591
[TBL] [Abstract][Full Text] [Related]
10. Lynch syndrome presenting as endometrial cancer.
Tafe LJ; Riggs ER; Tsongalis GJ
Clin Chem; 2014 Jan; 60(1):111-21. PubMed ID: 24193118
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
[TBL] [Abstract][Full Text] [Related]
12. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
13. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
[TBL] [Abstract][Full Text] [Related]
14. Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disorders.
Le S; Ansari U; Mumtaz A; Malik K; Patel P; Doyle A; Khachemoune A
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447627
[TBL] [Abstract][Full Text] [Related]
15. Cervical adenocarcinoma in a patient with Lynch syndrome, Muir-Torre variant.
Nair N; Curtin JP; Mittal K; Hiotis KL
J Clin Oncol; 2012 Jan; 30(2):e5-6. PubMed ID: 22124091
[No Abstract] [Full Text] [Related]
16. Mismatch repair deficiency testing in clinical practice.
Buza N; Ziai J; Hui P
Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Lynch syndrome identification in selected and unselected gynecological cancers.
Carnevali I; Sahnane N; Chiaravalli AM; Di Lauro E; Facco C; Facchi S; Casarin J; Ghezzi F; Sessa F; Tibiletti MG
Eur J Cancer Prev; 2022 Jul; 31(4):369-376. PubMed ID: 34519692
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results.
Ryan N; Wall J; Crosbie EJ; Arends M; Bosse T; Arif S; Faruqi A; Frayling I; Ganesan R; Hock YL; McMahon R; Manchanda R; McCluggage WG; Mukonoweshuro P; van Schalkwyk G; Side L; Smith JH; Tanchel B; Evans DG; Gilks CB; Singh N
Histopathology; 2019 Dec; 75(6):813-824. PubMed ID: 31310679
[TBL] [Abstract][Full Text] [Related]
19. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
[TBL] [Abstract][Full Text] [Related]
20. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.
Hampel H; Pearlman R; de la Chapelle A; Pritchard CC; Zhao W; Jones D; Yilmaz A; Chen W; Frankel WL; Suarez AA; Cosgrove C; Backes F; Copeland L; Fowler J; O'Malley D; Salani R; McElroy JP; Stanich PP; Goodfellow P; Cohn DE
Gynecol Oncol; 2021 Jan; 160(1):161-168. PubMed ID: 33393477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
